BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17919834)

  • 1. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.
    Kupelian PA; Willoughby TR; Reddy CA; Klein EA; Mahadevan A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1146-50. PubMed ID: 17919834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.
    Kupelian PA; Thakkar VV; Khuntia D; Reddy CA; Klein EA; Mahadevan A
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1463-8. PubMed ID: 16169683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers.
    Engels B; Soete G; Verellen D; Storme G
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):388-91. PubMed ID: 19056185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.
    de Crevoisier R; Tucker SL; Dong L; Mohan R; Cheung R; Cox JD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):965-73. PubMed ID: 15989996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
    Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
    Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland.
    Mohan DS; Kupelian PA; Willoughby TR
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):575-80. PubMed ID: 10701736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
    Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
    O'Daniel JC; Dong L; Zhang L; de Crevoisier R; Wang H; Lee AK; Cheung R; Tucker SL; Kudchadker RJ; Bonnen MD; Cox JD; Mohan R; Kuban DA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):883-91. PubMed ID: 17011461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy.
    Pawlowski JM; Yang ES; Malcolm AW; Coffey CW; Ding GX
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):924-34. PubMed ID: 20004528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.
    Park SS; Yan D; McGrath S; Dilworth JT; Liang J; Ye H; Krauss DJ; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):947-52. PubMed ID: 22208964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer.
    Kupelian PA; Langen KM; Zeidan OA; Meeks SL; Willoughby TR; Wagner TH; Jeswani S; Ruchala KJ; Haimerl J; Olivera GH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):876-82. PubMed ID: 17011460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.